Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study

•We evaluate the effect of 6-cycle completion and earlier use of radium-233 dichloride (Ra223) on the prognosis of patients with metastatic castration-resistant prostate cancer (mCRPC)•We retrospectively evaluated 75 patients with bone metastases-predominant mCRPC who were treated with Ra223 to asse...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Urologic oncology 2022-02, Vol.40 (2), p.64.e1-64.e8
Hauptverfasser:	Sasaki, Daichi, Hatakeyama, Shingo, Kawaguchi, Hideo, Hatayama, Yoshiomi, Ishibashi, Yusuke, Kusaka, Ayumu, Noro, Daisuke, Tanaka, Toshikazu, Ito, Hiroyuki, Okuyama, Yoshiharu, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Aoki, Masahiko, Ohyama, Chikara
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Humans Male Metastatic castration-resistant prostate cancer Prognosis Prostatic Neoplasms, Castration-Resistant - drug therapy Radium - pharmacology Radium - therapeutic use Radium-223 Retrospective Studies Six cycles Skeletal-related events Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!